Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis and human rights].

Hideaki Nagai1, Tomokazu Inagaki, Emiko Toyoda

  • 1Department of Respiratory Diseases, National Hospital Organization Tokyo National Hospital, 3-1-1, Takeoka, Kiyose-shi, Tokyo 204-8585, Japan. hnagai@tokyo.hosp.go.jp

Kekkaku : [Tuberculosis]
|April 21, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical manifestations of adult patients requiring influenza-associated hospitalization in the pre-, during, and post-COVID-19 pandemic periods: An internet-based, prospective, multicenter, cohort study in Japan.

Respiratory investigation·2026
Same author

Comparison of baloxavir/marboxil treatment and treatment with other anti-influenza agents in adult patients hospitalized for influenza: An internet-based, prospective, multicenter, cohort study in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Plain language summary of TASUKI-52: A study looking at nivolumab plus platinum chemotherapy and bevacizumab as a combined treatment for people with advanced or recurrent nonsquamous non-small cell lung cancer (NSCLC).

Future oncology (London, England)·2026
Same author

Four-Year Outcomes for Nivolumab With Chemotherapy and Bevacizumab in Patients With Nonsquamous NSCLC in the TASUKI-52.

Cancer science·2026
Same author

All-case post-marketing surveillance of delamanid for treating multidrug-resistant pulmonary tuberculosis in Japan.

Respiratory investigation·2026
Same author

Serum cytokine analysis in cavitary and non-cavitary pulmonary Mycobacterium avium complex disease: a cross-sectional study.

BMC infectious diseases·2025

Restricting human rights of noncooperative tuberculosis (TB) patients involves balancing patient rights with public health. Further discussion is needed for legal revisions and national consensus on TB control policies.

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • Tuberculosis (TB) transmission necessitates hospitalization for infectious patients, but non-adherence poses public health challenges.
  • Balancing patient autonomy with the rights of the wider community is crucial in TB control strategies.
  • Discussions on restricting human rights of non-cooperative TB patients highlight the need for a balanced approach.

Framework:

  • Scientific evidence on isolation periods suggests 2-3 weeks of effective treatment may reduce contagiousness, though not eliminate risk.
  • Analysis of hospitalized TB patients revealed reasons for discontinued hospitalization, including non-compliance, homelessness, and dementia, indicating a need for legal intervention.
  • International perspectives, particularly from the US, emphasize criteria for mandatory health policies: demonstrable harm to others, least restrictive means, and equitable implementation.

Related Experiment Videos

Implementation:

  • Directly Observed Therapy (DOT) is important for compliance but may not meet criteria for mandatory policies.
  • Legal and ethical considerations for revising TB control policies require balancing patient rights with public safety.
  • The symposium highlighted the current situation and legal challenges in Japan regarding TB patient management and human rights.

Implications:

  • Revising the Tuberculosis Protection Act requires further discussion and national consensus.
  • A societal understanding of TB as a "social illness" is essential for successful treatment completion and social defense.
  • Future TB control policies must integrate scientific evidence, legal frameworks, and ethical considerations to protect both patients and the public.